Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection

MLA

Brandie D. Wagner, et al. “Limited Effects of Azithromycin on the Oropharyngeal Microbiome in Children with CF and Early Pseudomonas Infection.” BMC Microbiology, vol. 23, no. 1, Oct. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12866-023-03073-8.

APA

Brandie D. Wagner, Edith T. Zemanick, Scott D. Sagel, Charles E. Robertson, Mark J. Stevens, Nicole Mayer-Hamblett, George Retsch-Bogart, Bonnie W. Ramsey, & J. Kirk Harris. (2023). Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection. BMC Microbiology, 23(1), 1–11. https://doi.org/10.1186/s12866-023-03073-8

Chicago

Brandie D. Wagner, Edith T. Zemanick, Scott D. Sagel, Charles E. Robertson, Mark J. Stevens, Nicole Mayer-Hamblett, George Retsch-Bogart, Bonnie W. Ramsey, and J. Kirk Harris. 2023. “Limited Effects of Azithromycin on the Oropharyngeal Microbiome in Children with CF and Early Pseudomonas Infection.” BMC Microbiology 23 (1): 1–11. doi:10.1186/s12866-023-03073-8.